Plasmion GmbH

Plasmion GmbH develops advanced mass spectrometry solutions, focusing on their innovative SICRIT® ion source technology to enhance the analysis of volatile organic compounds (VOCs) across diverse industries. Founded in 2016 in Augsburg, Germany, Plasmion GmbH specializes in mass spectrometry technology, specifically the SICRIT® ion source. The company has successfully completed 2 deals, with its most recent funding round being a Series A in June 2022, raising EUR 1. 000 mn from BayBG and High-Tech Gruenderfonds.

The current valuation of the company is EUR 9. 271 mn. The founder, Thomas Wolf, has a notable history in scientific innovation, having previously contributed to advancements in related fields. Plasmion specializes in advanced mass spectrometry solutions, with a primary focus on their SICRIT® ion source technology, which revolutionizes the analysis of volatile organic compounds (VOCs) in industrial applications.

Their products are designed to simplify and optimize laboratory analyses while providing real-time, automated in-line measurements. The SICRIT® technology caters to a variety of sectors, including food safety, pharmaceuticals, and forensics, allowing for precise chemical profiling and emission monitoring. Plasmion's key offerings have applications in diverse geographical markets, including North America, Europe, and Asia, targeting clients such as research institutions, manufacturing facilities, and regulatory agencies committed to maintaining high safety and quality standards. Plasmion generates revenue through direct sales of their SICRIT® ion sources and related analytical solutions to a diverse client base, which includes academic institutions, governmental agencies, and private sector companies.

The company's transaction structure is primarily B2B, leveraging partnerships with larger firms and distributors for broader market reach. Clients typically engage in one-time purchases or long-term contracts for ongoing support and maintenance services, ensuring optimal performance of the analytical systems. The flagship SICRIT® products command premium pricing due to their unique capabilities and the sophisticated technology behind them, appealing to organizations prioritizing high-quality analytical results. Following the recent funding round in June 2022, Plasmion GmbH is focusing on the development of new products leveraging their SICRIT® technology.

The company plans to expand its market presence by entering additional regions such as Asia and Europe by the end of 2023. The recent funding will be utilized to support the design and launch of these upcoming products as well as to enhance their marketing efforts in new geographic areas.